John Brancaccio, Former Director at Cardiff Oncology, holds 16.67K shares in OKYO Pharma Limited Sponsored ADR (Ticker: OKYO), holds 12.26K shares in Cardiff Oncology (Ticker: CRDF), holds 7.01K shares in Hepion Pharmaceuticals (Ticker: HEPA). Most recently, John Brancaccio Bought ― shares of OKYO Pharma Limited Sponsored ADR on Sep 28, 2023 for an estimated value of 25.00K.
What is the percentage of profitable transactions made by John Brancaccio?
The percentage of profitable transactions made by John Brancaccio is 29%.
What is the average return per transaction made by John Brancaccio?
The average return per transaction made by John Brancaccio is 25.00%.
What stocks does John Brancaccio hold?
John Brancaccio holds: CRDF, HEPA, OKYO, SGYPQ stocks.
What was John Brancaccio’s latest transaction?
John Brancaccio latest transaction was an Informative Buy of $25.00K.
What was John Brancaccio's most profitable transaction?
John Brancaccio’s most profitable transaction was an Informative Buy of CRDF stock on May 18, 2020. The return on the trade was 371.00%.
What is John Brancaccio's role in Cardiff Oncology?
John Brancaccio's role in Cardiff Oncology is Former Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.